1. Home
  2. ARTL vs AEMD Comparison

ARTL vs AEMD Comparison

Compare ARTL & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$5.86

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

HOLD

Current Price

$2.17

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTL
AEMD
Founded
2011
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.6M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
ARTL
AEMD
Price
$5.86
$2.17
Analyst Decision
Hold
Hold
Analyst Count
2
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
5.9M
60.5K
Earning Date
05-12-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$0.31
52 Week High
$28.60
$5.89

Technical Indicators

Market Signals
Indicator
ARTL
AEMD
Relative Strength Index (RSI) 50.95 51.68
Support Level $2.24 $1.93
Resistance Level $6.16 $2.44
Average True Range (ATR) 2.41 0.14
MACD -0.28 0.01
Stochastic Oscillator 17.37 38.72

Price Performance

Historical Comparison
ARTL
AEMD

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Share on Social Networks: